# clm_E89A362E23D2

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: operating_income  
value: -205,159,000 United States dollar  
valid_from: 2011-12-31  
valid_to: 2012-12-31  
published: 2012-02-21  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_38E3B92F967E  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals operating income: -205,159,000 United States dollar", as of 2011-12-31 (until 2012-12-31). Claim clm_E89A362E23D2, https://asof.is/claim/clm_E89A362E23D2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-21  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm (primary, SEC EDGAR 10-K FY2011, published 2012-02-21)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | -97,472,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_E89A362E23D2](/claim/clm_E89A362E23D2.md) | [clm_244D0F6FC089](/claim/clm_244D0F6FC089.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.